Exchange: OTC·Updated 03:51 PM EST

EGRX Eagle Pharmaceuticals Inc

$0.65
$0.25
(27.78%)
Today
Mkt Cap$11.72M
Vol2,407.00

About EGRX

Eagle Pharmaceuticals, Inc. is a biotechnology pharmaceutical company, which focuses on developing and commercializing injectable products primarily in the metabolic critical care and oncology areas in the United States. Its products include BYFAVO, PEMFEXY, RYANODEX, BENDEKA, and BELRAPZO. The company was founded by Scott L. Tarriff on January 2, 2007 and is headquartered in Woodcliff Lake, NJ.
48

Neutral Sentiment

How do you feel about EGRX?

Freddy7672
$EGRX Following its June 2026 acquisition of RYANODEX® from Eagle Pharmaceuticals, and successful supply chain transition, Cosette is leveraging its established manufacturing and distribution capabilities to maintain a dependable supply of this critical treatment option for healthcare providers.
1

Advertisement|Remove ads.